Specific Aim 1: To evaluate the combined therapy for symptomatic hormone-independent metastatic prostate cancer. Specific Aim 2: To evaluate the synergy of combined therapy in treating primary and non-symptomatic metastatic prostate tumor.
|Effective start/end date||10/1/18 → 10/31/20|
- U.S. Army Medical Research and Materiel Command (W81XWH-15-1-0406)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.